Free sign-up Sign in
Free sign-up Sign in
GlobalData

< View all reports

Type 2 Diabetes: Competitive Landscape to 2026

GlobalData expects new drug approvals to drive T2D market growth over the next decade (2016–2026).

Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition influenced by diet and lifestyle. Insulin is a hormone that regulates the glucose level in blood. Raised blood sugar (hyperglycemia) is an instant consequence of diabetes, and over time leads to serious tissue damage, affecting the heart, blood vessels, eyes, kidneys, and nerves. This report is part of our Biosimilars market series.

Doctor
  • Report Scope:
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies
  • Get an understanding of trends shaping and driving the global T2D market
  • Understand innovative products and technologies, market segments, and companies likely to impact the global T2D market in future
  • Analyze performance of competitors in the T2D space

The T2D pipeline features 551 products across all stages of clinical development, with non-‘me-too’ drugs prominently featured in early-stage clinical trials. Metabolic diseases R&D efforts are focused on T2D, with 7,840 clinical trials (based on clinical trials initiated from 1995 to now).

T2D clinical trials focus on cardiovascular outcomes, with 24.4% of clinical trials in ongoing status, however only 3% of clinical trials are planned for initiation. New drug approvals are expected to drive T2D market growth over the next decade.

GlobalData’s Biosimilars market report provides in-house analyst expertise and a competitive assessment of the disease market. This report will allow you to assess the pipeline, clinical, and commercial landscape of T2D.

Purchase Today

Single user $ 3,495

Buy Now

reportstore@globaldata.com

+44 (0) 161 359 5813

Not ready to buy yet? Download our free report series guide on the Biosimilars Market

I consent to GlobalData collecting my details provided via this form.

You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our GlobalData Privacy Policy to see how we protect and manage your submitted data.